The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Abstract
Parkinson's disease (PD), one of the most frequent neurodegenerative disorders, is no longer considered a complex motor disorder characterized by extrapyramidal symptoms, but a progressive multisystem or—more correctly—multiorgan disease with variegated neurological and nonmotor deficiencies. It is morphologically featured not only by the degeneration of the dopaminergic nigrostriatal system, responsible for the core motor deficits, but by multifocal involvement of the central, peripheral and autonomic nervous system and other organs associated with widespread occurrence of Lewy bodies and dystrophic Lewy neurites. This results from deposition of abnormal α‐synuclein (αSyn), the major protein marker of PD, and other synucleinopathies. Recent research has improved both the clinical and neuropathological diagnostic criteria of PD; it has further provided insights into the development and staging of αSyn and Lewy pathologies and has been useful in understanding the pathogenesis of PD. However, many challenges remain, for example, the role of Lewy bodies and the neurobiology of axons in the course of neurodegeneration, the relation between αSyn, Lewy pathology, and clinical deficits, as well as the interaction between αSyn and other pathologic proteins. Although genetic and experimental models have contributed to exploring the causes, pathomechanisms, and treatment options of PD, there is still a lack of an optimal animal model, and the etiology of this devastating disease is far from being elucidated. © 2011 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–342 of 342
Involvement of the cerebellothalamocortical pathway in Parkinson disease
Ni, Z., Pinto, A. D., Lang, A. E., & Chen, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.22221 · Cited by 153
Lewis, M. M., Du, G., Sen, S., Kawaguchi, A., Truong, Y., Lee, S., Mailman, R. B., & Huang, X. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.060 · Cited by 151
Elstner, M., Morris, C. M., Heim, K., Bender, A., Mehta, D., Jaros, E., Klopstock, T., Meitinger, T., Turnbull, D. M., & Prokisch, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0828-9 · Cited by 150
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
Kalaitzakis, M. E., Christian, L., Moran, L. B., Graeber, M. B., Pearce, R. K. B., & Gentleman, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.007 · Cited by 150
Genetic mouse models of Parkinson’s disease
Magen, I., & Chesselet, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84004-x · Cited by 147
Characterizing mild cognitive impairment in Parkinson's disease
Dalrymple‐Alford, J. C., Livingston, L., MacAskill, M. R., Graham, C., Melzer, T. R., Porter, R., Watts, R., & Anderson, T. (2011) · Movement Disorders · doi:10.1002/mds.23592 · Cited by 146
Progression of monoaminergic dysfunction in parkinson's disease: a longitudinal 18f-dopa pet study
Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L., & Brooks, D. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.012 · Cited by 145
Striatal β-Amyloid Deposition in Parkinson Disease With Dementia
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816362aa · Cited by 145
HART, M. N. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181839bfd · Cited by 145
Morphological differences in Parkinson’s disease with and without rest tremor
Benninger, D. H., Thees, S., Kollias, S., Bassetti, C. L., & Waldvogel, D. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0092-2 · Cited by 144
Francis, P. T., & Perry, E. K. (2007) · Movement Disorders · doi:10.1002/mds.21683 · Cited by 141
Greffard, S., Verny, M., Bonnet, A.-M., Seilhean, D., Hauw, J., & Duyckaerts, C. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.015 · Cited by 138
[11C]PIB binding in Parkinson's disease dementia
Maetzler, W., Reimold, M., Liepelt, I., Solbach, C., Leyhe, T., Schweitzer, K. J., Eschweiler, G. W., Mittelbronn, M. G. A., Gaenslen, A., Uebele, M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.09.072 · Cited by 137
Tandé, D., Höglinger, G. U., Debeir, T., Freundlieb, N., Hirsch, É. C., & François, C. (2006) · Brain · doi:10.1093/brain/awl041 · Cited by 136
Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease
Zhou, J., Broe, M., Huang, Y. M., Anderson, J. P., Gai, W., Milward, E. A., Porritt, M. J., Howells, D. W., Hughes, A. J., Wang, X., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0815-1 · Cited by 135
Fumimura, Y., Ikemura, M., Saito, Y., Sengoku, R., Kanemaru, K., Sawabe, M., Arai, T., Ito, G., Iwatsubo, T., Fukayama, M., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180517454 · Cited by 134
Sossi, V., de la Fuente‐Fernández, R., Schulzer, M., Troiano, A. R., Ruth, T. J., & Stoessl, A. J. (2007) · Annals of Neurology · doi:10.1002/ana.21204 · Cited by 133
Wakisaka, Y., Furuta, A., Tanizaki, Y., Kiyohara, Y., Iida, M., & Iwaki, T. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0750-x · Cited by 133
Tsuboi, Y., Uchikado, H., & Dickson, D. W. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70005-1 · Cited by 132
Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease
Parkkinen, L., Soininen, H. S., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 131
Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics
Sollinger, A. B., Goldstein, F. C., Lah, J. J., Levey, A. I., & Factor, S. A. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.11.002 · Cited by 129
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0313-7 · Cited by 128
Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?
Double, K. L., Reyes, S., Werry, E. L., & Halliday, G. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.001 · Cited by 126
Evidence in favor of Braak staging of Parkinson's disease
Dickson, D. W., Uchikado, H., Fujishiro, H., & Tsuboi, Y. (2010) · Movement Disorders · doi:10.1002/mds.22637 · Cited by 126
Regional differences in the severity of Lewy body pathology across the olfactory cortex
Silveira‐Moriyama, L., Holton, J. L., Kingsbury, A. E., Ayling, H., Petrie, A., Sterlacci, W., Poewe, W. H., Maier, H., Lees, A. J., & Révész, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.006 · Cited by 123
The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I
Litvan, I., Halliday, G. M., Hallett, M., Goetz, C. G., Rocca, W. A., Duyckaerts, C. J., Ben‐Shlomo, Y., Dickson, D. W., Lang, A. E., Chesselet, M., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180415e42 · Cited by 122
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
Picconi, B., Paillé, V., Ghiglieri, V., Bagetta, V., Barone, I., Lindgren, H. S., Bernardi, G., Cenci, M. A., & Calabresi, P. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.10.001 · Cited by 122
Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy
Orimo, S., Kanazawa, T., Nakamura, A., Uchihara, T., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0160-y · Cited by 122
Iron and reactive oxygen species activity in parkinsonian substantia nigra
del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 121
McMillan, P. J., White, S. S., Franklin, A., Greenup, J. L., Leverenz, J. B., Raskind, M. A., & Szot, P. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.015 · Cited by 119
Ubiquitination of α-synuclein and autophagy in Parkinson's disease
Engelender, S. (2008) · Autophagy · doi:10.4161/auto.5604 · Cited by 118
Halliday, G. M., Tredici, K. D., & Braak, H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_16 · Cited by 117
Modifications of the iron–neuromelanin system in Parkinson's disease
Fasano, M., Bergamasco, B., & Lopiano, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03638.x · Cited by 117
New dopaminergic neurons in Parkinson's disease striatum
Porritt, M. J., Batchelor, P., Hughes, A. J., Kalnins, R. M., Donnan, G. A., & Howells, D. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02437-5 · Cited by 117
Relationships between Lewy bodies and pale bodies in Parkinson's disease
Dale, G. E., Probst, A., Luthert, P., Martin, J., Anderton, B. H., & Leigh, P. N. (1992) · Acta Neuropathologica · doi:10.1007/bf00310030 · Cited by 114
Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Duka, T., Rusnak, M., Drolet, R. E., Duka, V., Wersinger, C., Goudreau, J. L., & Sidhu, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6092com · Cited by 114
Preservation of hypothalamic dopaminergic neurons in Parkinson's disease
Matzuk, M. M., & Saper, C. B. (1985) · Annals of Neurology · doi:10.1002/ana.410180507 · Cited by 114
Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 110
Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies
Deramecourt, V., Bombois, S., Maurage, C., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F., & Delacourte, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000205145.54457.ea · Cited by 109
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism
Deutch, A. Y., Colbran, R. J., & Winder, D. J. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70012-9 · Cited by 107
Kozikowski, A. P., Gaisina, I. N., Petukhov, P. A., Sridhar, J., King, L. T., Blond, S. Y., Duka, T., Rusnak, M., & Sidhu, A. (2006) · ChemMedChem · doi:10.1002/cmdc.200500039 · Cited by 107
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
Frasier, M. A., Walzer, M., McCarthy, L., Magnuson, D. J., Lee, J. M., Haas, C. A., Kahle, P. J., & Wolozin, B. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.07.016 · Cited by 106
Benarroch, E. E., Schmeichel, A. M., Low, P. A., & Parisi, J. E. (2007) · Brain · doi:10.1093/brain/awl357 · Cited by 106
Hornykiewicz, O. (2008) · Neurodegenerative Diseases · doi:10.1159/000113678 · Cited by 104
Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
Kovács, G. G., Botond, G., & Budka, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0658-1 · Cited by 103
Lewy body disease with and without dementia: a clinicopathological study of 35 cases.
Kosaka, K., Tsuchiya, K., & Yoshimura, M. (1988) · PubMed · Cited by 103
In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution
Weisman, D., Cho, M., Taylor, C., Adame, A., Thal, L. J., & Hansen, L. A. (2007) · Neurology · doi:10.1212/01.wnl.0000266626.64913.0f · Cited by 100
Inflammation and Parkinson's disease pathogenesis
Przedborski, S. (2010) · Movement Disorders · doi:10.1002/mds.22638 · Cited by 100
Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease
Fujita, M., Ichise, M., Zoghbi, S. S., Liow, J., Ghose, S., Vines, D. C., Sangare, J., Lu, J., Cropley, V., Iida, H., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20688 · Cited by 100
Katsuse, O., Iseki, E., Marui, W., & Kosaka, K. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00037-6 · Cited by 98
Brooks, D. J. (2009) · Movement Disorders · doi:10.1002/mds.22581 · Cited by 97
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
Elbaz, A., Ross, O. A., Ioannidis, J. P. A., Soto‐Ortolaza, A. I., Moisan, F., Aasly, J. O., Annesi, G., Bozi, M., Brighina, L., Chartier‐Harlin, M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22321 · Cited by 96
Fujishiro, H., Tsuboi, Y., Lin, W.-L., Uchikado, H., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0383-1 · Cited by 96
Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia
Lee, J., Zhu, W.-M., Stanić, D., Finkelstein, D. I., Horne, M. H., Henderson, J. M., Lawrence, A. J., O’Connor, L., Tomas, D., Drago, J., et al. (2008) · Brain · doi:10.1093/brain/awn085 · Cited by 95
Aluise, C. D., Robinson, R. A. S., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101083 · Cited by 94
Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
Halliday, G. M., Song, Y. J. C., & Harding, A. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0641-6 · Cited by 94
Müller, C. M., de Vos, R. A. I., Maurage, C., Thal, D. R., Tolnay, M., & Braak, H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171652.40083.15 · Cited by 94
Mattila, P. M., Rinne, J. O., Helenius, H. Y. M., & Röyttä, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051064 · Cited by 94
Lee, S. H., Kim, S. S., Tae, W., Lee, S. Y., Choi, J. W., Koh, S., & Kwon, D. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2372 · Cited by 94
Degenerative Diseases of the Nervous System
Hankey, G., & Wardlaw, J. M. (2008) · CRC Press eBooks · doi:10.1201/b17272-18 · Cited by 94
Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 93
Microglial cells and Parkinson’s disease
Li, Q., & Flood, P. M. (2008) · Immunologic Research · doi:10.1007/s12026-008-8018-0 · Cited by 93
Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide
McKeith, I. G. (2007) · Practical Neurology · doi:10.1136/jnnp.2007.134163 · Cited by 92
The morbid anatomy of dementia in Parkinson’s disease
Kalaitzakis, M. E., & Pearce, R. K. B. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0597-x · Cited by 91
Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment
Adler, C. H., Caviness, J. N., Sabbagh, M. N., Shill, H. A., Connor, D. J., Sue, L. I., Evidente, V. G. H., Driver‐Dunckley, E. D., & Beach, T. G. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0744-4 · Cited by 90
Qureshi, H. Y., & Paudel, H. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178905 · Cited by 90
Mori, F., Nishie, M., Kakita, A., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000230520.47768.1a · Cited by 89
Common Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease
Mrak, R. E., & Griffin, W. S. T. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812503e1 · Cited by 87
Morphological substrates of dementia in parkinsonism A critical update
Jellinger, K. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_6 · Cited by 85
Self-citationStrecker, K., Wegner, F., Hesse, S., Becker, G., Patt, M., Meyer, P., Lobsien, D., Schwarz, J., & Sabri, O. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5666-5 · Cited by 85
Involvement of medullary regions controlling sympathetic output in Lewy body disease
Benarroch, E. E. (2004) · Brain · doi:10.1093/brain/awh376 · Cited by 85
Ghebremedhin, E., Rosenberger, A., Rüb, U., Vukšić, M., Berhe, T., Bickeböller, H., de Vos, R. A. I., Thal, D. R., & Deller, T. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d88e63 · Cited by 84
Characterization of antibodies that selectively detect α-synuclein in pathological inclusions
Waxman, E. A., Duda, J. E., & Giasson, B. I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0375-1 · Cited by 81
Parkinson's disease: Insights from non-traditional model organisms
Pienaar, I. S., Götz, J., & Feany, M. Β. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.001 · Cited by 79
Involvement of the ventrolateral medulla in parkinsonism with autonomic failure
Benarroch, E. E., AS, A. M. S., & Parisi, J. E. (2000) · Neurology · doi:10.1212/wnl.54.4.963 · Cited by 79
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_12 · Cited by 77
Self-citationLi, W., Hoffman, P. N., Stirling, W. L. H., Price, D. L., & Lee, M. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02166.x · Cited by 74
Significance of Brain Lesions in Parkinson Disease Dementia and Lewy Body Dementia
Jellinger, K. A. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000197890 · Cited by 74
Self-citationGhebremedhin, E., Tredici, K. D., Langston, J. W., & Braak, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0596-y · Cited by 74
Olfactory system pathology as a model of Lewy neurodegenerative disease
Duda, J. E. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.042 · Cited by 74
Dementia with Lewy bodies from the perspective of tauopathy
Iseki, E., Togo, T., Suzuki, K., Katsuse, O., Marui, W., de Silva, R., Lees, A. J., Yamamoto, T., & Kosaka, K. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0644-3 · Cited by 72
Hippocampal neuron and glial cell numbers in Parkinson's disease—A stereological study
Joelving, F. C., Billeskov, R., Christensen, J. R., West, M. J., & Pakkenberg, B. (2006) · Hippocampus · doi:10.1002/hipo.20212 · Cited by 72
Silveira‐Moriyama, L., Schwingenschuh, P., O'Donnell, A., Schneider, S. A., Mir, P., Carrillo, F., Terranova, C., Petrie, A., Grosset, D. G., Quinn, N. P., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.172825 · Cited by 72
Lv, Z., Jiang, H. F., Xu, H., Song, N., & Xie, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0434-3 · Cited by 71
Fujishiro, H., Iseki, E., Higashi, S., Kasanuki, K., Murayama, N., Togo, T., Katsuse, O., Uchikado, H., Aoki, N., Kosaka, K., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.036 · Cited by 70
Lesions outside the CNS in Parkinson's disease
Djaldetti, R., Lev, N., & Melamed, E. (2009) · Movement Disorders · doi:10.1002/mds.22172 · Cited by 70
Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease
Mastaglia, F. L., Johnsen, R. D., Byrnes, M. L., & Kakulas, B. A. (2002) · Movement Disorders · doi:10.1002/mds.10295 · Cited by 70
Clues to how alpha‐synuclein damages neurons in Parkinson's disease
Sulzer, D. (2010) · Movement Disorders · doi:10.1002/mds.22639 · Cited by 69
Controversies over the staging of α-synuclein pathology in Parkinson’s disease
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0381-3 · Cited by 68
Kanazawa, T., Uchihara, T., Takahashi, A., Nakamura, A., Orimo, S., & Mizusawa, H. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00140.x · Cited by 67
Piggott, M. A., Perry, E. K., Marshall, E. F., McKeith, I. G., Johnson, M. K., Melrose, H. L., COURT, J. A., Lloyd, S. R., FAIRBAIRN, A. F., Brown, A. D., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00127-9 · Cited by 67
Xie, W., Wan, O. W., & Chung, K. K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.014 · Cited by 67
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
Riederer, P., Gerlach, M., Müller, T., & Reichmann, H. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.06.015 · Cited by 63
Reetz, K., Gaser, C., Klein, C., Hagenah, J. M., Büchel, C., Gottschalk, S., Pramstaller, P. P., Siebner, H. R., & Binkofski, F. (2008) · Movement Disorders · doi:10.1002/mds.22333 · Cited by 61
α-Synuclein pathology in the neostriatum in Parkinson’s disease
Mori, F., Tanji, K., Zhang, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0316-4 · Cited by 61
Cognitive Characteristics Associated with Mild Cognitive Impairment in Parkinson’s Disease
McKinlay, A., Grace, R. C., Dalrymple‐Alford, J. C., & Roger, D. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000235247 · Cited by 61
Environmental neurotoxin‐induced progressive model of parkinsonism in rats
Shen, W., McDowell, K. A., Siebert, A. A., Clark, S. M., Dugger, N. V., Valentino, K. M., Jinnah, H. A., Sztalryd, C., Fishman, P. S., Shaw, C. A., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22018 · Cited by 60
Synaptic plasticity, dopamine and Parkinson's disease: one step ahead
Calabresi, P., Mercuri, N. B., & Filippo, M. D. (2008) · Brain · doi:10.1093/brain/awn340 · Cited by 59
Neuropathologic Findings of Dementia with Lewy Bodies (DLB) in a Population-based Vantaa 85+ Study
Oinas, M., Polvikoski, T. M., Sulkava, R. O., Myllykangas, L., Juva, K., Notkola, I.-L. K., Rastas, S., Niinistö, L., Kalimo, H., & Paetau, A. E. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1169 · Cited by 58
Baum, L., Seger, R., Woodgett, J. R., Kawabata, S., Maruyama, K., Koyama, M., Silver, J. E., & Saitoh, T. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00111-5 · Cited by 58
Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
Lanoue, A. C., Dumitriu, A., Myers, R. H., & Soghomonian, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.09.001 · Cited by 58
Nigral burden of α‐synuclein correlates with striatal dopamine deficit
Kovács, G. G., Milenković, I., Preusser, M., & Budka, H. (2008) · Movement Disorders · doi:10.1002/mds.22207 · Cited by 57
Ito, H., Kusaka, H., Matsumoto, S., & Imai, T. (1996) · Neurology · doi:10.1212/wnl.47.5.1291 · Cited by 57
Neuroimaging and Cognition in Parkinson's Disease Dementia
Silbert, L. C., & Kaye, J. A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00368.x · Cited by 56
Wilhelmus, M. M. M., Verhaar, R., Andringa, G., Bol, J. G. J. M., Cras, P. P., Shan, L., Hoozemans, J. J. M., & Drukarch, B. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00429.x · Cited by 56
α-synuclein induced synapse damage is enhanced by amyloid-β1-42
Bate, C., Gentleman, S., & Williams, A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-55 · Cited by 55
No global loss of neocortical neurons in parkinson's disease: A quantitative stereological study
Pedersen, K. M., Marner, L., Pakkenberg, H., & Pakkenberg, B. (2004) · Movement Disorders · doi:10.1002/mds.20289 · Cited by 55
Characteristics of alpha-synucleinopathy in centenarians
Ding, Z., Wang, Y., Jiang, Y., Hashizume, Y., Yoshida, M., Mimuro, M., Inagaki, T., & Iwase, T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0015-y · Cited by 53
Duka, T., & Sidhu, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033329 · Cited by 51
Amyloid β‐peptide and the dementia of Parkinson's diease
Jendroska, K., Lees, A. J., Poewe, W. H., & Daniel, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110609 · Cited by 49
Dugger, B. N., & Dickson, D. W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0739-1 · Cited by 49
New animal models of Parkinson's disease
Dehay, B., & Bézard, E. (2011) · Movement Disorders · doi:10.1002/mds.23546 · Cited by 46
Atypical Protein Kinase C in Neurodegenerative Disease II
Shao, C., Crary, J. F., Rao, C., Sacktor, T. C., & Mirra, S. S. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000218441.00040.82 · Cited by 46
Neuropathology in Parkinson’s disease with mild cognitive impairment
Jellinger, K. A. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0755-1 · Cited by 45
Self-citationSimplified neuropathological diagnosis of dementia with Lewy bodies
Harding, & Halliday (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00115.x · Cited by 45
Familial aggregation of Parkinson's disease in a multiethnic community‐based case‐control study
Shino, M. Y., McGuire, V. M., Eeden, S. K. V. D., Tanner, C. M., Popat, R. A., Leimpeter, A. D., BERNSTEIN, A. L., & Nelson, L. M. (2010) · Movement Disorders · doi:10.1002/mds.23361 · Cited by 44
Cerebral correlates of psychotic syndromes in neurodegenerative diseases
Jellinger, K. A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01311.x · Cited by 43
Self-citationPathologic Correlates of Dementia in Individuals with Lewy Body Disease
Sonnen, J. A., Postupna, N. O., Larson, E. B., Crane, P. K., Rose, S. E., Montine, K. S., Leverenz, J. B., & Montine, T. J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00371.x · Cited by 42
Zhou, Z., Lan, Y. H., Tan, E. K., & Lim, T. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.010 · Cited by 41
Djaldetti, R., Lorberboym, M., Karmon, Y., Treves, T. A., Ziv, I., & Melamed, E. (2010) · Movement Disorders · doi:10.1002/mds.23380 · Cited by 40
Wakabayashi, K., Mori, F., & Takahashi, H. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.05.028 · Cited by 39
Braak, H., Thal, D. R., & Tredici, K. D. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0508-2 · Cited by 37
Lewy body‐related α‐synucleinopathy in the spinal cord of cases with incidental Lewy body disease
Tamura, T., Yoshida, M., Hashizume, Y., & Sobue, G. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01211.x · Cited by 36
Lee, F. J. S., Wang, Y.-T., & Liu, F. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:245 · Cited by 35
Non-dopamine Lesions in Parkinson's Disease
(2010) · Oxford University Press eBooks · doi:10.1093/med/9780195371086.001.0001 · Cited by 34
Are we making progress in the understanding of tremor in Parkinson's disease?
Hallett, M., & Deuschl, G. (2010) · Annals of Neurology · doi:10.1002/ana.22253 · Cited by 34
Pan-Montojo, F. J., & Funk, R. H. W. (2010) · Journal of Visualized Experiments · doi:10.3791/2123 · Cited by 33
Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft
Sebastián, W. S., López-Guillén, J. L., Manrique, M. J., Belzunegui, S., Ciordia, E., Izal‐Azcárate, A., Garrido‐Gil, P., Vázquez‐Claverie, M., & Luquín, M. R. (2007) · Brain · doi:10.1093/brain/awm061 · Cited by 32
A Tangled Web – Tau and Sporadic Parkinson's Disease
Wray, S., & Lewis, P. A. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00150 · Cited by 32
Non-Motor Symptoms of Parkinson's Disease
Weerkamp, N. J., van Ommen‐Nijhof, A., & Tissingh, G. (2009) · Oxford University Press eBooks · doi:10.1093/med/9780199237234.001.0001 · Cited by 29
Systematic Appraisal Using Immunohistochemistry of Brain Pathology in Aged and Demented Subjects
Aho, L., Parkkinen, L., Pirttilä, T., & Alafuzoff, I. I. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000122963 · Cited by 27
Rate of 6‐[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease
Gallagher, C. L., Oakes, T. R., Johnson, S. C., Chung, M. K., Holden, J. E., Bendlin, B. B., McLaren, D. G., Xu, G., Nickles, R. J., Pyzalski, R. W., et al. (2011) · Movement Disorders · doi:10.1002/mds.23503 · Cited by 25
Parkinson's disease dementia – A diminished role for the Lewy body
Libow, L. S., Frisina, P. G., Haroutunian, V. H., Perl, D. P., & Purohit, D. P. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.003 · Cited by 24
Striatal dopaminergic neurons are lost with Parkinson's disease progression
Porritt, M. J., Kingsbury, A. E., Hughes, A. J., & Howells, D. W. (2006) · Movement Disorders · doi:10.1002/mds.21129 · Cited by 24
Pathology of Parkinson's Disease
Halliday, G. M., & Murphy, K. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00009-x · Cited by 17
Thalamic stimulation for tremor: Can target determination be improved?
Bardinet, É., Belaïd, H., Grabli, D., Welter, M., Fernández-Vidal, S., Galanaud, D., Derrey, S., Dormont, D., Cornu, P., Yelnik, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23448 · Cited by 17
IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION
Jellinger, K. A. (2008) · Neurology · doi:10.1212/01.wnl.0000304033.82293.9a · Cited by 16
Self-citationNonmotor Aspects of Parkinson's Disease
TOLOSA, E. S., Santamaría, J., Gaig, C., & Compta, Y. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00014-3 · Cited by 13
Regulation of Dopaminergic Neuronal Death by Endogenous Dopamine and Proteasome Activity
Izumi, Y., Kume, T., & Akaike, A. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.21 · Cited by 11
Jellinger, K. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00291-4 · Cited by 8
Self-citationMild Cognitive Impairment in Parkinson’s Disease: A Critical Update
Jellinger, K. A. (2011) · Aging Health · doi:10.2217/ahe.10.80 · Cited by 4
Self-citationα-Synuclein and Parkinson's Disease
Gasser, T. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00003-9 · Cited by 2
Cited by
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., & Bartus, R. T. (2013) · Brain · doi:10.1093/brain/awt192 · Cited by 1,286
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Parkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 707
Thenganatt, M. A., & Jankovic, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6233 · Cited by 506
Metadata
- Authors
- Jellinger, K. A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2011-11-11
- Volume
- 27
- Issue
- 1
- Pages
- 8-30
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1979444935
- Cited by
- 451
- References
- 342
- FWCI
- 19.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.